Efficacy of Ibrutinib in the Treatment of Monoclonal Gammopathy of Renal Significance with C3 Deposits Secondary to Chronic Lymphocytic Leukemia. acbr [Internet]. 2025 Sep. 22 [cited 2026 Sep. 17];9(5):360-3. Available from: https://fortunejournals.org/ojs/index.php/acbr/article/view/15131